Contribution of Conventional Cardiovascular Risk Factors to Brain White Matter Hyperintensities

Background White matter hyperintensities (WMHs) are a major risk factor for stroke and dementia, but their pathogenesis is incompletely understood. It has been debated how much risk is accounted for by conventional cardiovascular risk factors (CVRFs), and this has major implications as to how effective a preventative strategy targeting these risk factors will be. Methods and Results We included 41 626 UK Biobank participants (47.2% men), with a mean age of 55 years (SD, 7.5 years), who underwent brain magnetic resonance imaging at the first imaging assessment beginning in 2014. The relationships among CVRFs, cardiovascular conditions, and WMH volume as a percentage of total brain volume were examined using correlations and structural equation models. Only 32% of the variance in WMH volume was explained by measures of CVRFs, sex, and age, of which age accounted for 16%. CVRFs combined accounted for ≈15% of the variance. However, a large portion of the variance (well over 60%) remains unexplained. Of the individual CVRFs, blood pressure parameters together accounted for ≈10.5% of the total variance (diagnosis of hypertension, 4.4%; systolic blood pressure, 4.4%; and diastolic blood pressure, 1.7%). The variance explained by most individual CVRFs declined with age. Conclusions Our findings suggest the presence of other vascular and nonvascular factors underlying the development of WMHs. Although they emphasize the importance of modification of conventional CVRFs, particularly hypertension, they highlight the need to better understand risk factors underlying the considerable unexplained variance in WMHs if we are to develop better preventative approaches.

[1]  F. de Leeuw,et al.  The global burden of cerebral small vessel disease in low- and middle-income countries: A systematic review and meta-analysis , 2022, International journal of stroke : official journal of the International Stroke Society.

[2]  W. M. van der Flier,et al.  Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE): A Review. , 2022, JAMA neurology.

[3]  M. van Buchem,et al.  Different cardiovascular risk factors are related to distinct white matter hyperintensity MRI phenotypes in older adults , 2022, NeuroImage: Clinical.

[4]  L. Becker,et al.  Association of Coronary Artery Atherosclerosis With Brain White Matter Hyperintensity , 2021, Stroke.

[5]  Guy B. Williams,et al.  Microglial activation and blood–brain barrier permeability in cerebral small vessel disease , 2021, Brain : a journal of neurology.

[6]  R. Wachter,et al.  Heart failure is independently associated with white matter lesions: insights from the population‐based LIFE‐Adult Study , 2020, ESC heart failure.

[7]  N. Eriksson,et al.  Cerebral small vessel disease genomics and its implications across the lifespan , 2020, Nature Communications.

[8]  Alejandro F Frangi,et al.  The UK Biobank imaging enhancement of 100,000 participants: rationale, data collection, management and future directions , 2020, Nature Communications.

[9]  C. Lewis,et al.  Genome-wide association study of MRI markers of cerebral small vessel disease in 42,310 participants , 2020, Nature Communications.

[10]  Eric E. Smith,et al.  New Treatment Approaches to Modify the Course of Cerebral Small Vessel Diseases. , 2019, Stroke.

[11]  Jackson T. Wright,et al.  Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions. , 2019, JAMA.

[12]  M. Dichgans,et al.  Small vessel disease: mechanisms and clinical implications , 2019, The Lancet Neurology.

[13]  J. Williamson,et al.  Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial , 2019, JAMA.

[14]  S. Larsson,et al.  Clinical Significance of Magnetic Resonance Imaging Markers of Vascular Brain Injury: A Systematic Review and Meta-analysis , 2019, JAMA neurology.

[15]  E. Frangou,et al.  Association of Cardiovascular Risk Factors With MRI Indices of Cerebrovascular Structure and Function and White Matter Hyperintensities in Young Adults , 2018, JAMA.

[16]  M. Jorge Cardoso,et al.  White matter hyperintensities and vascular risk factors in monozygotic twins , 2018, Neurobiology of Aging.

[17]  Majaz Moonis,et al.  Atrial fibrillation is associated with anterior predominant white matter lesions in patients presenting with embolic stroke , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[18]  Ludovica Griffanti,et al.  Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank , 2017, NeuroImage.

[19]  Ludovica Griffanti,et al.  BIANCA (Brain Intensity AbNormality Classification Algorithm): A new tool for automated segmentation of white matter hyperintensities , 2016, NeuroImage.

[20]  Yves Rosseel,et al.  Useful Tools for Structural Equation Modeling , 2015 .

[21]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[22]  I. Deary,et al.  Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities , 2014, Neurology.

[23]  F. Gaita,et al.  Prevalence of silent cerebral ischemia in paroxysmal and persistent atrial fibrillation and correlation with cognitive function. , 2013, Journal of the American College of Cardiology.

[24]  Yves Rosseel,et al.  lavaan: An R Package for Structural Equation Modeling , 2012 .

[25]  Kristopher J Preacher,et al.  Advantages of Monte Carlo Confidence Intervals for Indirect Effects , 2012 .

[26]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[27]  Carole Dufouil,et al.  Antihypertensive Treatment and Change in Blood Pressure Are Associated With the Progression of White Matter Lesion Volumes: The Three-City (3C)–Dijon Magnetic Resonance Imaging Study , 2011, Circulation.

[28]  Tanya N. Beran,et al.  Structural equation modeling in medical research: a primer , 2010, BMC Research Notes.

[29]  W. M. van der Flier,et al.  Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[30]  H. Markus,et al.  The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis , 2010, BMJ : British Medical Journal.

[31]  P. Scheltens,et al.  Brain magnetic resonance imaging abnormalities in patients with heart failure , 2007, European journal of heart failure.

[32]  D. Streiner Building a Better Model: An Introduction to Structural Equation Modelling , 2006, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[33]  Charles DeCarli,et al.  Genetic Variation in White Matter Hyperintensity Volume in the Framingham Study , 2004, Stroke.

[34]  David P Mackinnon,et al.  Confidence Limits for the Indirect Effect: Distribution of the Product and Resampling Methods , 2004, Multivariate behavioral research.

[35]  James C. Anderson,et al.  STRUCTURAL EQUATION MODELING IN PRACTICE: A REVIEW AND RECOMMENDED TWO-STEP APPROACH , 1988 .

[36]  C. Escobar Cervantes,et al.  [A randomized trial of intensive versus standard blood pressure control]. , 2016, Semergen.